Helix-8
Helix8 (Health Engineering Life Science Innovation Exchange) is Saudi Arabia's premier biotech commercialisation platform, designed to bridge the gap between scientific innovation and market success. As the operational core of the WISE Initiative, Helix8 serves as a strategic accelerator that transforms promising biotech ventures into commercially viable enterprises. Rather than conducting primary research or deploying capital directly, Helix8 provides critical infrastructure access, regulatory navigation expertise, and ecosystem partnerships that enable biotech companies to thrive in the Kingdom. Fully aligned with Saudi Vision 2030 and the National Biotechnology Strategy, Helix8 leverages partnerships with leading institutions including KAUST, KACST, and KFSHRC to offer world-class support services. Through its unique positioning alongside the Taranis Capital Biotech KSA Fund, Helix8 creates a seamless pathway from innovation to investment to commercialisation, positioning Saudi Arabia as a regional hub for life sciences excellence.
https://helix-8.com/
